Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Centene Corporation (CNC)

NYSE Health Care Managed Health Care S&P 500
$69.74
-4.43 (-5.97%)
Close of Nov 06, 2026 · end-of-day data
Source: Centene Corporation's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 03, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$37.58B$45.62B$56.44B$70.36B$103.80B$117.98B$135.48B$140.09B$145.50B$174.58B
Cost of revenue$1.86B$1.85B$2.39B$2.46B$3.30B$4.89B$7.03B$3.56B$2.73B$2.67B
Gross profit$35.72B$43.77B$54.05B$67.90B$100.50B$14.49B$16.92B$17.64B$17.07B$14.21B
Selling, general & admin$3.67B$4.45B$6.04B$6.53B$9.38B$9.60B$11.59B$12.56B$12.40B$12.90B
Operating income$1.26B$1.20B$1.46B$1.78B$3.08B$1.78B$1.32B$2.93B$3.17B-$7.62B
Interest expense$217.00M$255.00M$343.00M$412.00M$728.00M$665.00M$665.00M$725.00M$702.00M$678.00M
Pre-tax income$1.16B$1.13B$1.37B$1.78B$2.77B$1.81B$1.96B$3.60B$4.26B-$6.73B
Income tax$599.00M$326.00M$474.00M$473.00M$979.00M$477.00M$760.00M$899.00M$963.00M-$51.00M
Net income$562.00M$828.00M$900.00M$1.32B$1.81B$1.35B$1.20B$2.70B$3.31B-$6.67B
EBITDA$1.54B$1.56B$1.95B$2.42B$4.34B$3.12B$2.75B$4.22B$4.42B-$6.35B
EPS (basic)$1.76$2.40$2.31$3.19$3.17$2.31$2.09$4.97$6.33$-13.53
EPS (diluted)$1.71$2.34$2.26$3.14$3.12$2.28$2.07$4.95$6.31$-13.53
Diluted shares327.95M353.40M398.51M420.41M579.13M590.52M582.04M545.70M523.74M493.12M
Gross margin95.0%96.0%95.8%96.5%96.8%12.3%12.5%12.6%11.7%8.1%
Operating margin3.4%2.6%2.6%2.5%3.0%1.5%1.0%2.1%2.2%-4.4%
Net margin1.5%1.8%1.6%1.9%1.7%1.1%0.9%1.9%2.3%-3.8%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$3.93B$4.07B$5.34B$12.12B$10.80B$13.12B$12.07B$17.19B$14.06B$17.89B
Short-term investments$505.00M$531.00M$722.00M$863.00M$1.58B$1.54B$2.32B$2.46B$2.62B$2.43B
Total current assets$8.37B$8.70B$12.00B$20.32B$23.39B$28.50B$30.13B$40.76B$38.00B$40.37B
Goodwill$4.71B$4.75B$7.01B$6.86B$18.65B$19.77B$18.81B$17.56B$17.56B$10.84B
Total assets$20.20B$21.86B$30.90B$40.99B$68.72B$78.38B$76.87B$84.64B$82.44B$76.75B
Total current liabilities$8.62B$9.33B$11.97B$12.93B$21.59B$25.77B$28.46B$36.72B$34.26B$36.72B
Short-term debt$4.00M$4.00M$38.00M$88.00M$97.00M$267.00M$82.00M$119.00M$110.00M$50.00M
Long-term debt$4.65B$4.70B$6.65B$13.64B$16.68B$18.57B$17.94B$17.71B$18.42B$17.35B
Total debt$4.66B$4.70B$6.69B$13.73B$16.78B$18.84B$18.02B$17.83B$18.53B$17.40B
Total liabilities$14.14B$14.98B$19.88B$28.30B$42.76B$51.35B$52.63B$58.69B$55.94B$56.69B
Shareholders' equity$5.89B$6.85B$10.92B$12.55B$25.77B$26.80B$24.06B$25.84B$26.41B$19.95B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$1.85B$1.49B$1.23B$1.48B$5.50B$4.21B$6.26B$8.05B$154.00M$5.09B
Capital expenditures$306.00M$422.00M$675.00M$730.00M$869.00M$910.00M$1.00B$799.00M$644.00M$767.00M
Free cash flow$1.54B$1.07B$559.00M$753.00M$4.63B$3.29B$5.26B$7.25B-$490.00M$4.32B
Investing cash flow-$2.47B-$1.25B-$4.58B-$1.53B-$6.96B-$3.30B-$2.92B-$1.19B-$1.05B$472.00M
Financing cash flow$2.72B-$82.00M$4.61B$6.83B$260.00M$1.36B-$4.20B-$1.66B-$2.41B-$1.62B
Share buybacks$63.00M$65.00M$71.00M$75.00M$626.00M$297.00M$3.10B$1.63B$3.12B$475.00M
Stock-based compensation$148.00M$135.00M$145.00M$177.00M$281.00M$203.00M$234.00M$216.00M$212.00M$204.00M
Depreciation & amortization$278.00M$361.00M$495.00M$643.00M$1.26B$1.33B$1.43B$1.29B$1.24B$1.27B

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.